JSPR · Jasper Therapeutics, Inc.
AI read · Good for JSPR
The AI's read
More patients are now being studied across several kidney diseases. Early findings could help show whether the treatment helps. The update does not report patient results yet. Jasper also says its Kira purchase came with about $132 million from a preferred-stock sale. That provides cash for its work, but the report does not say how long the cash will last.